FI901087A7 - Atsolidiinidionijohdannaisia - Google Patents

Atsolidiinidionijohdannaisia Download PDF

Info

Publication number
FI901087A7
FI901087A7 FI901087A FI901087A FI901087A7 FI 901087 A7 FI901087 A7 FI 901087A7 FI 901087 A FI901087 A FI 901087A FI 901087 A FI901087 A FI 901087A FI 901087 A7 FI901087 A7 FI 901087A7
Authority
FI
Finland
Prior art keywords
azolidinedione derivatives
azolidinedione
derivatives
Prior art date
Application number
FI901087A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI901087A0 (fi
Inventor
Reinhard Sarges
Steven Wayne Goldstein
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI901087A0 publication Critical patent/FI901087A0/fi
Publication of FI901087A7 publication Critical patent/FI901087A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/20Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI901087A 1987-09-04 1987-09-04 Atsolidiinidionijohdannaisia FI901087A7 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/002196 WO1989001775A1 (en) 1987-09-04 1987-09-04 Azolidinedione derivatives

Publications (2)

Publication Number Publication Date
FI901087A0 FI901087A0 (fi) 1990-03-02
FI901087A7 true FI901087A7 (fi) 1990-03-02

Family

ID=22202540

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901087A FI901087A7 (fi) 1987-09-04 1987-09-04 Atsolidiinidionijohdannaisia

Country Status (21)

Country Link
EP (1) EP0306251A3 (enExample)
JP (1) JPS6471882A (enExample)
KR (1) KR900008841B1 (enExample)
CN (1) CN1022325C (enExample)
AU (1) AU595467B2 (enExample)
CS (1) CS273186B2 (enExample)
DD (1) DD273381A5 (enExample)
DK (1) DK488688A (enExample)
EG (1) EG18591A (enExample)
FI (1) FI901087A7 (enExample)
HU (1) HU204832B (enExample)
IL (1) IL87590A (enExample)
MX (1) MX12896A (enExample)
MY (1) MY103765A (enExample)
NO (1) NO901016L (enExample)
PH (1) PH24957A (enExample)
PL (1) PL156798B1 (enExample)
PT (1) PT88407B (enExample)
WO (1) WO1989001775A1 (enExample)
YU (1) YU46863B (enExample)
ZA (1) ZA886507B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5068333A (en) * 1990-03-07 1991-11-26 Pfizer Inc. 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration
DE10210195B4 (de) 2002-03-07 2005-12-15 Schwarz Pharma Ag Verwendung von 1,3-Diazaspiro-[4,5]decan-2,4-dithion zur Behandlung von Schmerz
PT1873145E (pt) * 2005-04-21 2012-12-03 Ishihara Sangyo Kaisha Método de produção de um derivado do ácido nicotínico ou de um seu sal

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
ATE11781T1 (de) * 1981-05-13 1985-02-15 Imperial Chemical Industries Plc Pharmazeutische zubereitungen, die spirosuccinimidderivate enthalten.

Also Published As

Publication number Publication date
PL274504A1 (en) 1989-05-02
DD273381A5 (de) 1989-11-15
NO901016D0 (no) 1990-03-02
YU167788A (en) 1990-06-30
PT88407A (pt) 1989-07-31
YU46863B (sh) 1994-06-24
DK488688A (da) 1989-04-07
AU595467B2 (en) 1990-03-29
FI901087A0 (fi) 1990-03-02
CN1031702A (zh) 1989-03-15
AU2184188A (en) 1989-03-09
NO901016L (no) 1990-05-02
PT88407B (pt) 1992-10-30
EG18591A (en) 1993-06-30
CS273186B2 (en) 1991-03-12
PH24957A (en) 1990-12-26
MX12896A (es) 1993-06-01
KR900008841B1 (ko) 1990-11-30
IL87590A (en) 1992-07-15
ZA886507B (en) 1990-04-25
DK488688D0 (da) 1988-09-02
EP0306251A2 (en) 1989-03-08
HUT56106A (en) 1991-07-29
CN1022325C (zh) 1993-10-06
WO1989001775A1 (en) 1989-03-09
MY103765A (en) 1993-09-30
KR890005112A (ko) 1989-05-11
JPS6471882A (en) 1989-03-16
IL87590A0 (en) 1989-01-31
CS591188A2 (en) 1990-06-13
HU204832B (en) 1992-02-28
EP0306251A3 (en) 1990-08-01
PL156798B1 (pl) 1992-04-30
JPH0583554B2 (enExample) 1993-11-26

Similar Documents

Publication Publication Date Title
TR26815A (tr) Azolilmetil-sikropil türevleri
DK263587D0 (da) Imidazoquinolinyletherderivater
DK295288D0 (da) (1h-azol-1-ylmethyl)substituerede benzotriazolderivater
ATA312487A (de) Tetrahydrocarbazolonderivate
DK321088A (da) Thiazolidindionderivater
TR24894A (tr) N-FENILPIRAZOL TüREVLERI
DK507188A (da) Cholecalciferolderivater
DK693587A (da) Alkansulfonanilidderivater
DK378088A (da) Alkenderivater
DK49688A (da) Propiolophenonderivater
DK691287D0 (da) 5-floururacilderivater
DK271088A (da) Tienopyridinderivater
DK444687A (da) Alfa-substituerede ketonitron-derivater
FI893041A7 (fi) Substituoidut atsasykloheksyylijohdannaiset
DK495188A (da) Ekspressionsvektor
DK695788D0 (da) Naphtalenderivater
IT8721345A0 (it) Perossiacidi eterociclici
DK619187A (da) Isoindolderivater
DK440687A (da) Bicyclooctanderivater
DK229887A (da) Alkenamidderivater
FI901087A7 (fi) Atsolidiinidionijohdannaisia
FI885063A7 (fi) Uudet 4-demetoksi-antrasykliinijohdannaiset
DK435087A (da) Isoprenderivater
DK71488A (da) Dipenylethylen-derivater
DK733688D0 (da) Dioxazocinderivater

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: PFIZER INC.